Location of Repository

Efficacy and effectiveness of the combination of sulfadoxine/pyrimethamine and a 3-day course of artesunate for the treatment of uncomplicated falciparum malaria in a refugee settlement in Zambia.

By E Depoortere, J P Guthmann, J Pressé, N Sipilanyambe, E Nkandu, S Balkan, P E de Pécoulas and D Legros

Abstract

In the Maheba Refugee Settlement, in the clinics supported by Medecins Sans Frontieres, all children aged up to 5 years with a confirmed diagnosis of uncomplicated falciparum malaria are treated with the combination of sulfadoxine/pyrimethamine (SP) and artesunate (AS). We compared the treatment's efficacy and effectiveness. Patients were randomized in order to receive the treatment supervised (efficacy) or unsupervised (effectiveness). Therapeutic response was determined after 28 days of follow up. The difference between recrudescence and re-infection was ascertained by polymerase chain reaction (PCR). We also assessed genetic markers associated to SP resistance (dhfr and dhps). Eighty-five patients received treatment under supervision and 84 received it unsupervised. On day 28, and after PCR adjustment, efficacy was found to be 83.5% (95% CI: 74.1-90.5), and effectiveness 63.4% (95% CI: 52.6-73.3) (P < 0.01). Point mutations on dhfr (108) and dhps (437) were found for 92.0% and 44.2% respectively of the PCR samples analysed. The significant difference in therapeutic response after supervised and unsupervised treatment intake can only be explained by insufficient patient adherence. When implementing new malaria treatment policies, serious investment in ensuring patient adherence is essential to ascertain the effectiveness of the new treatment schedules

Publisher: Wiley-Blackwell
Year: 2005
DOI identifier: 10.1111/j.1365-3156.2004.01363.x
OAI identifier: oai:fieldresearch.msf.org:10144/17251
Provided by: MSF Field Research
Journal:

Suggested articles

Preview

Citations

  1. (2004). Adherence to the combination of sulfadoxine-pyrimethamine and artesunate
  2. (2004). Artesunate combinations for treatment of malaria: meta-analysis.
  3. (1999). Averting a malaria disaster.
  4. (2001). Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure?
  5. (2000). Chloroquine- and sulfadoxine-pyrimethamine resistant falciparum malaria in vivo – a pilot study in rural Zambia.
  6. (2002). Combination therapy for malaria.
  7. (1999). Control Centre (Compiled by) (2000) Drug Sensitivity Study Summary Report.
  8. (1999). Delaying antimalarial drug resistance with combination chemotherapy.
  9. (2001). Drug Resistance in Malaria. World Health Organization,
  10. (2005). Efficacy and effectiveness of ACT, Zambia 144 ª 2005 Blackwell Publishing Ltd Authors Evelyn Depoortere (corresponding author), Jean-Paul Guthmann and Dominique Legros, Epicentre, 8 rue Saint Sabin,
  11. (2000). Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.
  12. (1988). Evidence that a point mutation in dihydrofolate-reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria.
  13. (2002). Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infectious Diseases 2,
  14. (2002). Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.
  15. (2000). Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase of isolates from the Amazon region of Brazil. Memorias do Instituto Oswaldo Cruz 95,
  16. (1995). PCR typing of field isolates of Plasmodium falciparum.
  17. (1996). Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria.
  18. (2001). The public health impact of chloroquine resistance in Africa.
  19. The way forward?
  20. (1996). World Health Organisation (WHO)

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.